Mirae Asset Global ETFs Holdings’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Mirae Asset Global ETFs Holdings's BIIB Position: Q2 2026 in Review
Mirae Asset Global ETFs Holdings reduced its Biogen (BIIB) stake by 65% in Q2 2026, selling an estimated $7.5M and leaving 21,557 shares worth $4.66M. The position accounts for 0.01% of the portfolio, ranked #888.
Mirae Asset Global ETFs Holdings first reported a position in BIIB in Q2 2024 and has held it in 9 quarters since. The position peaked at $29.7M in Q2 2024. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Mirae Asset Global ETFs Holdings held 21,557 shares of Biogen worth $4.66M as of Q2 2026.
- Mirae Asset Global ETFs Holdings sold 39,219 Biogen shares in Q2 2026, an estimated $7.5M.
- Biogen made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #888 holding.
- Mirae Asset Global ETFs Holdings first reported a position in Biogen in Q2 2024 and has held it in 9 quarters since.
- Mirae Asset Global ETFs Holdings's Biogen position peaked at $29.7M in Q2 2024.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.